Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> PFIZER Latest News

APR 18, 2014 - Yahoo! News

A Must Read - Share

Exclusive: Biogen prices hemophilia drug on par with older therapies

Biogen Idec Inc is pricing its newly-approved long-acting hemophilia drug to cost U.S. patients, and insurers, about the same per year as older, less convenient therapies whose price can reach about $300,000 annually. The move could pressure rivals such as Pfizer Inc to lower prices for existing hemophilia treatments, which provide patients with life-saving infusions of a blood clotting agent, ...

Tags: Exclusive: Biogen prices hemophilia drug on par with older therapies,  Pfizer Latest News

APR 17, 2014 - Philadelphia Inquirer

A Must Read - Share

Teva, Pfizer settle patent lawsuit over blockbuster painkiller

Teva Pharmaceutical Industries Ltd said it settled a patent lawsuit with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster painkiller Celebrex in December.

Tags: Teva, Pfizer settle patent lawsuit over blockbuster painkiller,  Pfizer Latest News

APR 17, 2014 - Wall Street Journal

A Must Read - Share

Teva Can Release Generic Celebrex by Year's End

Teva Pharmaceutical Industries Ltd. said Thursday it will be able to release its version of Celebrex in the U.S. by year's end after settling a patent dispute with Pfizer Inc.

Tags: Teva Can Release Generic Celebrex by Year's End,  Pfizer Latest News

APR 17, 2014 - Benzinga

A Must Read - Share

Teva Settles Patent Litigation with Pfizer on Celebrex; Has Received Tenative FDA Approval for All Strengths; May Start Generic Versions in December

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that its subsidiary Teva Pharmaceuticals USA, Inc. has entered into a settlement with Pfizer related to Teva's generic version of Celebrex® (celecoxib) 50, 100, 200 and 400 mg capsules in the United States.

Tags: Teva Settles Patent Litigation with Pfizer on Celebrex; Has Received Tenative FDA Approval for All Strengths; May Start Generic Versions in December,  Pfizer Latest News

APR 14, 2014 - Forbes

A Must Read - Share

On The 'Mad Men' Season 7 Premiere, Don Draper Hits Rock Bottom, Only To Find A Glimmer Of Hope

The  advance screener for the premier of Season Seven of Mad Men bore so many warnings, that I initially wondered whether it came from Pfizer instead of AMC.

Tags: On The 'Mad Men' Season 7 Premiere, Don Draper Hits Rock Bottom, Only To Find A Glimmer Of Hope,  Pfizer Latest News